BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Who Is CryoHoldco? Latin America’s Largest Cord Blood Bank

Who Is CryoHoldco? Latin America’s Largest Cord Blood Bank

March 1, 2021 By Cade Hildreth (CEO) Leave a Comment

CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and one of the top 10 largest cord blood banks in the world. CryoHoldco is now seven times larger than any other stem cell bank in Latin America and has over 275,000 stem cell units in storage.

Discover class-defining bioproduction tools.

Cryoholdco’s Origin

Cryoholdco was created in 2015 with the purpose of forming the premier stem cell banking company in Latin America. The first asset it acquired was Cryo-Cell Mexico, which coincidentally, was first stem cell bank formed in Latin America. Since investing in Cryo-Cell Mexico in mid 2015, CryoHoldco has been aggressively consolidating the Latin American market.

RoosterCollect EV Pro

Next, CryoHoldco acquired a controlling interest in a regional stem cell bank in Mexico in Q4 of 2015. In early 2016, it then acquired Stem Medicina Regenerativa, the largest stem cell bank in Colombia.

Today, Cryoholdco controls the following cord blood banking assets:

  • Mexico
    • Cryo-Cell Mexico
    • BCU
    • BSCU
    • DentCell (Dental stem cell storage company)
  • Colombia
    • Two assets in Columbia
  • Peru
    • Criocord
  • Brazil
    • It recently acquired two assets in Brazil

As a result of this expansion, CryoHoldco represents the largest stem cell banking operation in Latin America. The company features two state-of-the art lab and storage facilities in Mexico and Colombia, as well as a growing network of 10,000+ affiliated doctors and 100+ sales offices. CryoHoldco’s state-of–the-art storage facility in Guadalajara, Mexico, has the capacity to store 300,000 samples.

Its companies are the market leaders within their country and offer services nationwide.

According to Cryoholdco leadership, the market must be consolidated so the larger companies can “increase their investment in technology, state –of- the-art storage facilities, participate in clinical trials, improve operating performance, and invest in educational programs with doctors and clients to convey the benefits of storing cord blood and tissue.”

For additional details on Cryoholdco, read our interview with its CFO, James Alexis Mendez.

To learn more about this rapidly evolving industry, view the “Global Cord Blood Banking Industry Report 2021.”Cord Blood Market Report - BioInformant

5 / 5 ( 24 votes )

Filed Under: Cord Blood, HSCs, MSCs, Stem Cells Tagged With: cord blood, CryoHoldco, news

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Vitro Biopharma

Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells® to Treat COVID-19

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

MSC market

How the MSC Market is Coming of Age in 2021

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.